TAN LIP BU

Director TAN LIP BU sold 20,000 shares of CRDO at $175.12 (total $3.5M), reducing stake by 4.5%.

Director TAN LIP BU sold 20,000 shares at $175.12 on 2025-09-18, representing a 4.5% reduction in holdings from 442,180 to 422,180 shares. The sale price of $175.12 is 6.6% above the current price of $164.10 and near the 52-week high of $172.31, suggesting the director executed the sale at favorable valuations relative to recent price action. At the CRDO ticker, the insider's prior two measurable 90-day outcomes (from June 2025 sales) show positive returns of +81.6% and +79.4%, indicating those prior sales were poorly timed (the stock subsequently appreciated), though the company's fundamentals remain robust with FY revenue growth of +126.3% and a quarterly net income of $63.4M. The current sale occurs after a significant run-up: the stock has gained 43.9% over 30 days and 78.5% over 90 days, providing a window where a director might elect to sell at premium valuations.

Director Tan Lip Bu sold 25,000 shares at $161.98 average for $4.0M; stock now at $164.42 after 92.1% surge.

Tan Lip Bu executed 2 separate sales totaling 25,000 shares for $4,049,457.06 on 2025-09-12, reducing his CRDO holdings by 5.4% to 442,180 shares. The blended average sale price of $161.98 sits 1.5% below the current price of $164.42, reflecting a modest near-term miss—the stock has gained 92.1% over the prior 90 days and is currently at its 52-week high. His prior trades at CRDO show a timing pattern where 0 of 2 prior sells were well-timed at the 90-day mark, with those earlier sales captured gains of +90.3% and +111.3% (poorly timed exits that missed significant stock appreciation). Against this background, the present sale into a stock at its 52-week peak, following a 92.1% rally, is the only recent data point on this ticker's timing; the P/E of 228.36 and 126.3% annual revenue growth underscore valuation expansion alongside strong operational growth.

Director Tan Lip Bu sold 92,248 shares for $8,403,545.16 on 2025-06-24/25 near 52-week high of $95.05

Director Tan Lip Bu executed 3 separate sales totaling 92,248 shares for $8,403,545.16 over two trading days at an average price of $91.10, reducing his holdings by 16.5% to 467,180 shares post-transaction. The sales occurred as the stock traded near its 52-week high of $95.05 (the current price represents the top of the stock's recent range), following a 49.3% gain in the prior 30 days and a 134.6% gain over 90 days. His cross-ticker track record shows 20 prior sells with a 100.00% well-timed rate (mean 90-day return of -41.1%), though at this specific ticker (CRDO) his 5 most recent trades are too recent to measure outcomes. The company reported net income of $29,360,000.00 in the latest quarter against revenue of $135,002,000.00, though it was unprofitable over the most recent full fiscal year.

Director TAN LIP BU sold 54,297 shares of CRDO at $86.38 on 2025-06-18 for $4.7M, retaining 559,428 shares; stock near 52-week high.

TAN LIP BU sold 54,297 shares (-8.8% of prior holdings) at $86.38, just $1.21 below the 52-week high of $85.59, after the stock had appreciated 84.5% over the prior 90 days and 41.5% over the prior 30 days. The sale occurs amid strong recent price momentum and follows five other sales at this ticker within the preceding five days (2025-06-13 to 2025-06-16), suggesting a pattern of liquidation during a period of elevated valuation. Across his broader open-market trade history, the insider's 20 prior sells achieved a 90-day well-timed rate of 100.00%, yet at this specific ticker, outcomes on 5 prior trades remain unmeasurable or unresolved. The director retains substantial holdings (559,428 shares post-transaction), and the company's most recent quarterly financials show $135.0M in revenue with $29.4M net income, though full-year profitability turned negative.

Director Tan Lip Bu sells 171,473 shares for $13,358,179.41 across 4 transactions at $76.65–$79.12 on 2025-06-16

On 2025-06-16, Tan Lip Bu, a director at Credo Technology Group Holding Ltd (CRDO), executed 4 separate sales totaling 171,473 shares for $13,358,179.41, reducing his holdings from 785,198 to 613,725 shares (a 21.8% reduction). The sales occurred at prices ranging from $76.65 to $79.12, with a blended average of $77.90, significantly below the current stock price of $85.59. This transaction pattern warrants investor attention given two conflicting signals: the stock has risen 84.1% over 90 days and stands at its 52-week high of $85.59, yet the company was unprofitable over its most recent full fiscal year despite posting positive quarterly net income of $29,360,000.00 on revenue of $135,002,000.00. Across his broader open-market history, the insider has a 100% well-timed sell rate (90-day average return -40.9%), though his 5 prior trades specifically at CRDO are all too recent to measure outcomes, limiting confidence in tick-specific patterns.

Director Tan Lip Bu sold 103,527 shares for $7.8M (avg $75.36) on Jun 12–13; retained 785.2K shares. Stock +31.7% in 30d.

Tan Lip Bu, a Director at Credo Technology Group (CRDO), executed 2 separate sales totaling 103,527 shares for $7,801,600.94 at a blended average price of $75.36 on June 12–13, 2025. This represents an -11.6% reduction from his pre-transaction holdings of 888,725 shares. The sale occurred as the stock trades at $79.17 (current), down -7.4% from its 52-week high of $85.50, but notably the stock has gained +31.7% over the past 30 days and +79.6% over the past 90 days. Across his cross-ticker track record, Tan Lip Bu's prior 20 open-market sales achieved a 90-day well-timed rate of 100.00%, suggesting strong historical timing accuracy; however, his cross-ticker average 90-day return after sells was -41.4%, indicating the stock typically declines after his sales. At CRDO specifically, his 5 prior trades all occurred recently (concentrated around June 5–16) with no measurable 90-day outcomes yet available. The company reported latest-quarter revenue of $135,002,000.00 and net income of $29,360,000.00, though it was unprofitable on a full-year basis.

Director Tan Lip Bu sells 75,000 shares at blended avg $75.20; stock now $71.09. Pattern repeats: all 5 prior CRDO sales were well-timed, each followed by 90d declines.

Tan Lip Bu executed 2 separate sales totaling 75,000 shares for $5,640,260.76 on the same day, reducing holdings by 7.8%. Significantly, his prior trades at CRDO show a stark pattern: all 5 prior sales at this ticker were well-timed at the 90-day mark, with each sale followed by declines ranging from -35.2% to -56.2%. His cross-ticker track record shows a 90-day well-timed rate of 75.00%, but his ticker-specific record at CRDO is 100% successful timing on sells. The stock is currently trading at $71.09, down 16.8% from its 52-week high of $85.50, despite a 30-day rally of +39.9%. This latest sale at $75.20 occurs within a volatile stretch and extends a director-level exit pattern that has consistently preceded material share price declines.

Director TAN LIP BU sold 150,000 shares for $10.9M at blended $72.69 on 2025-01-15, reducing stake by 13.5%.

TAN LIP BU, a Director, executed 3 separate sales totaling 150,000 shares for $10,903,579.26 on 2025-01-15, reducing his holdings from 1,113,725 shares to 963,725 shares. The transaction occurred at prices ranging from $71.94 to $74.13, near the 52-week high of $77.25 (current price $75.60 is -2.1% from the 52-week high). The sale is noteworthy given Credo Technology's recent 90-day momentum of +102.6%, though the company remains unprofitable with net income of $-4,225,000.00 on quarterly revenue of $72,034,000.00. At CRDO specifically, this director's prior 5 trades show no measurable long-term directional pattern (0 of 0 prior sells at 90-day outcomes were well-timed), making this latest liquidation—a 13.5% reduction in holdings—a significant portfolio action without clear prior timing success at this ticker to contextualize it.

Director TAN LIP BU sold 150,000 shares of CRDO at $76.09 on 2025-01-06 for $11.4M, reducing stake by 11.9%

TAN LIP BU sold 150,000 shares at $76.09, just 4.2% below the 52-week high of $77.25, executing the sale near peak valuation. The sale reduces his holdings from 1,263,725 to 1,113,725 shares, a material 11.9% reduction in position size. Cross-ticker analysis shows his 20 prior open-market sales across all tickers averaged +19.5% returns over 30 days and +115.9% over 90 days, with a 0.00% well-timed rate—indicating his recent sales have been systematically poorly timed as stocks rallied post-sale. At CRDO specifically, five prior sales occurred in mid-December 2024 with measurable outcomes still pending. The company is unprofitable with full-year net income of $-4,225,000.00 and trailing quarterly revenue of $72,034,000.00, though annual growth is positive at 4.8%.

Director Tan Lip Bu sells 250,000 CRDO shares in 6 transactions (Dec 12–16) for $18.8M at blended avg $75.27; stock now at $77.25.

Director Tan Lip Bu executed 6 separate sales totaling 250,000 shares for $18,818,685.19 over a four-day window (December 12–16, 2024), reducing his holdings by 16.5% from 1,513,725 to 1,263,725 shares. The sales occurred at prices ranging from $69.00 to $77.53, with a blended average of $75.27, while the stock now trades at $77.25—near the top of its 52-week range of $16.92–$77.25 and up 94.3% over 30 days and 183.6% over 90 days. The timing coincides with a period of exceptional price momentum, and notably, the director completed five prior sales at CRDO on December 5–6, 2024, suggesting a sustained pattern of liquidation at peak valuations. The company reported a net loss of $4,225,000.00 in the latest quarter with only 4.8% annual revenue growth, raising questions about whether fundamentals justify the current stock elevation.